STOLFO, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 5.908
EU - Europa 5.331
AS - Asia 1.809
SA - Sud America 39
AF - Africa 35
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
Totale 13.141
Nazione #
US - Stati Uniti d'America 5.872
IT - Italia 2.819
PL - Polonia 893
SG - Singapore 609
CN - Cina 589
SE - Svezia 523
HK - Hong Kong 381
DE - Germania 266
BG - Bulgaria 120
IE - Irlanda 116
UA - Ucraina 116
FI - Finlandia 109
RU - Federazione Russa 63
GB - Regno Unito 59
TR - Turchia 57
IN - India 42
CH - Svizzera 41
KR - Corea 38
BE - Belgio 37
NL - Olanda 34
FR - Francia 33
VN - Vietnam 32
CA - Canada 26
AT - Austria 25
BR - Brasile 22
SN - Senegal 21
RO - Romania 20
JP - Giappone 19
GR - Grecia 14
ES - Italia 12
MX - Messico 10
IR - Iran 9
AU - Australia 8
EG - Egitto 8
CO - Colombia 7
EU - Europa 7
AR - Argentina 5
CZ - Repubblica Ceca 5
ID - Indonesia 5
MY - Malesia 5
DK - Danimarca 4
LT - Lituania 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
BH - Bahrain 3
CL - Cile 3
NO - Norvegia 3
TZ - Tanzania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
EE - Estonia 2
IL - Israele 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
SI - Slovenia 2
AL - Albania 1
HR - Croazia 1
HU - Ungheria 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MW - Malawi 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
TG - Togo 1
TW - Taiwan 1
Totale 13.141
Città #
Warsaw 888
Fairfield 779
Chandler 745
Ashburn 533
Singapore 498
Woodbridge 464
Hong Kong 374
Houston 354
Trieste 340
Seattle 322
Ann Arbor 319
Wilmington 283
Cambridge 245
Milan 233
Rome 197
Boardman 194
Princeton 165
Naples 130
Beijing 126
Jacksonville 123
Sofia 120
Columbus 119
Dublin 104
Santa Clara 78
Helsinki 66
Dearborn 62
Turin 57
Izmir 46
Grafing 44
Florence 41
San Diego 41
Catania 37
Brussels 34
Padova 34
Seoul 33
Bremen 32
Palermo 31
Genoa 30
Bari 28
Dong Ket 28
Udine 28
Nanjing 27
Washington 27
Los Angeles 26
Bologna 25
Des Moines 25
Mykolayiv 25
Redmond 25
Redwood City 24
Bern 23
Jinan 23
Dakar 21
Pune 20
Treviso 20
Venezia 20
Falls Church 19
Guangzhou 19
Venice 19
Verona 19
Shanghai 18
São Paulo 18
Vienna 18
London 17
Lappeenranta 15
Mestre 15
Munich 15
Kunming 14
Pescara 14
Shenyang 14
Toronto 14
Caserta 13
San Giovanni la Punta 13
Bergamo 12
Potenza 12
Amsterdam 10
Cagliari 10
Dongguan 10
Hefei 10
Norwalk 10
Phoenix 10
Athens 9
Brescia 9
Fremont 9
Hangzhou 9
Hebei 9
Latina 9
Messina 9
Rimini 9
Tokyo 9
Dallas 8
Fano 8
Leawood 8
Monfalcone 8
Mumbai 8
Nanchang 8
Napoli 8
Trento 8
Cernusco sul Naviglio 7
New York 7
San Francisco 7
Totale 9.260
Nome #
Linee guida sullo scompenso cardiaco a confronto: AHA 2022 versus ESC 2021 1.740
Cardiac fluid dynamics meets deformation imaging 370
Natural History of Dilated Cardiomyopathy in Children 353
Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist? 304
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 254
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy 226
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History 223
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 209
Treatment of Functional Mitral Regurgitation in Heart Failure 206
Left Ventricular Response to Cardiac Resynchronization Therapy: Insights From Hemodynamic Forces Computed by Speckle Tracking 204
Prognostic impact of short-term changes of E/E' ratio and left atrial size in dilated cardiomyopathy 204
Other cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 193
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 186
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome 185
Chapter 6: Clinical Presentation, Spectrum of Disease, and Natural History 184
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 181
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection 179
Evolving concepts in dilated cardiomyopathy 178
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy 177
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 170
Acute Hemodynamic Response to Cardiac Resynchronization in Dilated Cardiomyopathy: Effect on Late Mitral Regurgitation 168
Chapter 12: Prognostic Stratification and Importance of Follow-Up 167
Outcome of the multidimensional prognostic index in ultra-octogenarian patients hospitalized for cardiovascular diseases 166
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 163
Chronic thromboembolic pulmonary hypertension (CTEPH): what do we know about it? A comprehensive review of the literature 162
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach 161
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy 157
ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis 154
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 152
Early right ventricular response to cardiac resynchronization therapy: Impact on clinical outcomes 149
Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment. 147
Chapter 3: Pathophysiology 144
Coronary fistula of the left main artery draining in the right atrium and associated aorto-right atrial fistula 142
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 142
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? 134
Insights into mildly dilated cardiomyopathy: Temporal evolution and long-term prognosis 131
Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathyhttps://arts.units.it/submit?resume=115962# 130
Impact of patient delay in a modern real world STEMI network 130
Left ventricular reverse remodeling prediction in non-ischemic cardiomyopathy: present and perspectives 129
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 126
null 121
Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure Registry 121
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction 119
The Prognostic Impact of the Evolution of RV Function in Idiopathic DCM 117
ECG in dilated cardiomyopathy: Specific findings and long-term prognostic significance 117
Dilated cardiomyopathy: Dilated cardiomyopathy: Clinical assessment and differential diagnosis 115
Value of Strain Imaging and Maximal Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy 115
Calcific degeneration and rupture of the aortic valve and ascending aorta: From cardiac auscultation to multimodality imaging 108
Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure 101
Prognostic Value of Magnetic Resonance Phenotype in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy 97
Evidence-based Therapy in Older Patients with Heart Failure with Reduced Ejection Fraction 94
Prognostic significance of longitudinal strain in dilated cardiomyopathy with recovered ejection fraction 93
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 90
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 90
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 90
Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience 88
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy 87
Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences 86
Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy 86
Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy 84
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 84
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension 83
Early Arrhythmic Events in Idiopathic Dilated Cardiomyopathy 80
Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study 77
Risk of sudden cardiac death in New York Heart Association class I patients with dilated cardiomyopathy: A competing risk analysis 76
Prognostic Significance of Feature-Tracking Right Ventricular Global Longitudinal Strain in Non-ischemic Dilated Cardiomyopathy 70
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 70
Impaired Right Ventricular Longitudinal Strain Without Pulmonary Hypertension in Patients Who Have Recovered From COVID-19 69
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 68
Effect of prehospital treatment in STEMI patients undergoing primary PCI 67
Left Atrial Reverse Remodeling in Dilated Cardiomyopathy 66
Modifications of medical treatment and outcome after percutaneous correction of secondary mitral regurgitation 66
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 65
Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications 63
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 61
Right ventricular dysfunction in right coronary artery infarction: A primary PCI registry analysis 60
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 60
STEMI and Multivessel Disease: Medical Therapy Amplifies the Benefit of Complete Myocardial Revascularisation 59
Combining New Classes of Drugs for HFrEF: from Trials to Clinical Practice 57
The right ventricular involvement in dilated cardiomyopathy: prevalence and prognostic implications of the often-neglected child 56
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension 55
The Arrhythmic Phenotype in Cardiomyopathy 53
Advanced Heart Failure in Special Population: Cardiomyopathies and Myocarditis 53
A very rare cause of pre-capillary pulmonary hypertension: The PAMI syndrome 52
Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients 50
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 49
Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry. 48
Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring with Arrhythmic Risk in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy 48
Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications 47
Ventriculo-arterial uncoupling in acute heart failure: right heart is the matter 45
Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies 44
Heart failure with mid-range or mildly reduced ejection fraction 41
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator 40
Transient versus persistent improved ejection fraction in non-ischaemic dilated cardiomyopathy 40
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 39
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? 39
Using marginal structural joint models to estimate the effect of a time-varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy 37
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications 35
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 33
Assessment of Phasic Changes of Vascular Size by Automated Edge Tracking-State of the Art and Clinical Perspectives 31
Totale 13.135
Categoria #
all - tutte 42.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.528


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.471 0 0 0 0 143 214 230 173 263 154 137 157
2020/20211.875 144 185 156 303 171 144 165 128 98 177 84 120
2021/20221.352 67 82 67 75 85 125 63 43 137 142 136 330
2022/20233.242 188 291 294 420 270 415 151 291 314 150 287 171
2023/20242.484 204 161 169 220 213 266 390 303 63 108 242 145
2024/20251.495 113 207 385 396 394 0 0 0 0 0 0 0
Totale 13.792